Apogee Therapeutics, Inc. Members' Equity
Apogee Therapeutics, Inc. (APGE) had Members' Equity of $1.19 billion as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity
us-gaap:MembersEquity · last filed 2026-08-10
- 2026-06-30: Members' Equity $1.19B.
- 2026-03-31: Members' Equity $1.26B.
- 2025-12-31: Members' Equity $903.88M.
- 2025-09-30: Members' Equity $586.34M.
| Period end | Members' Equity |
|---|---|
| 2026-06-30 | $1.19B 10-Q · filed 2026-08-10 |
| 2026-03-31 | $1.26B 10-Q · filed 2026-08-10 |
| 2025-12-31 | $903.88M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $586.34M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $619.40M 10-Q · filed 2026-08-10 |
| 2025-03-31 | $673.36M 10-Q · filed 2026-08-10 |
| 2024-12-31 | $716.79M 10-Q · filed 2026-08-10 |
| 2024-09-30 | $734.40M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $773.64M 10-Q · filed 2025-11-10 |
| 2024-03-31 | $801.48M 10-Q · filed 2025-11-10 |
| 2023-12-31 | $379.91M 10-K · filed 2026-03-02 |
| 2023-09-30 | $409.24M 10-Q · filed 2024-11-12 |
| 2023-06-30 | -$64.42M 10-Q · filed 2024-11-12 |
| 2023-03-31 | -$46.64M 10-Q · filed 2024-11-12 |
| 2022-12-31 | -$35.39M 10-K · filed 2026-03-02 |
| 2022-09-30 | -$24.09M 10-Q · filed 2023-11-13 |
| 2022-06-30 | -$4.43M 10-Q · filed 2023-11-13 |
| 2022-03-31 | -$2.62M 10-Q · filed 2023-11-13 |
| 2022-02-03 | $0.00 10-K · filed 2024-03-05 |